Tuberculosis (TB) has killed more people than any other infectious disease in history. The air-borne disease is curable, yet through relative political and financial neglect, it remains a significant global public health problem, thriving in disadvantaged communities with little visibility.
Each year, more than 1.5 million people die from TB and another nine million people, many children, struggle to overcome the debilitating effects of the disease. The majority of the global burden is in the Asia-Pacific region.
Burnet’s breadth of cross-disciplinary expertise brings together a highly diverse approach to tackling infectious diseases of global significance, including TB.
The key goals of the Eliminate TB program are:
Working towards the global targets to eliminate TB as a public health threat by 2030 through partnerships, community engagement, technical assistance to national programs, and accelerating the implementation of innovation and research.
Developing and evaluating new tools, technologies and strategies for prevention, diagnosis, treatment and care, through discovery, translational and operational research.